Subscription Required

Only paid subscribers* to Specialty Pharmacy News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Specialty Pharmacy News receive

  • 12 monthly issues packed with news and strategies on this increasingly vital sector in health business, delivered First Class by U.S. Mail and electronically (optional),
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest grouped for convenient reading
    • Bonus reports for subscribers, and
    • Regular postings from your editor.
View a sample and get more information
October 2017

Recent Stories

From Specialty Pharmacy News - As medical innovation continues to expand by leaps and bounds, there has been a proliferation of new products coming onto the market. As such, it may be harder for some of these companies to reach health plans and procure reimbursement for the offerings. But a fairly new CareFirst subsidiary known as HealthWorx is working with such developers in order to help them get their products onto the market sooner, help gather evidence supporting the products’ use and ultimately help secure reimbursement from health plans. The company recently disclosed that it is working with a company known as Exosome Diagnostics, Inc. on a study of its prostate cancer test. Read more

A little more than 14 months after CMS launched its Oncology Care… Read more

When two drugs to treat hepatitis C launched in 2011, they were… Read more

As many home infusion providers continue to take a hit from a… Read more

From the Editor

Welcome to your Specialty Pharmacy News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with your comments on the last issue of Specialty Pharmacy News, story ideas for future issues, or any other suggestions you have that can make the newsletter more useful for you.

August 30, 2017
First Gene Therapy Gets FDA Approval

FDA approves first gene therapy in U.S., Novartis’ CAR-T drug Kymriah, for treatment of people up to 25 years old with B-cell precursor acute lymphoblastic leukemia that is refractory or has relapsed at least twice

August 2, 2017
CMS Unveils 2018 Standard Control Formulary

CMS will remove 17 drugs across 10 classes from its Standard Control Formulary in 2018, will launch Transform Value program in oncology, obesity, respiratory areas

July 31, 2017
Express Scripts Releases 2018 National Preferred Formulary

Express Scripts releases 2018 National Preferred Formulary, adding 64 drug exclusions for a total of 159. PBM says it expects employers who use the NPF will save an additional $2.5 billion next year

It's quick and easy to sign up for FREE access to!

Why do I need to register?